Direct AT2 receptor stimulation is athero-protective and stabilizes plaque in Apolipoprotein E-deficient mice

International Journal of Cardiology

Volumn 169, Issue 4, 2013, Pages 281-287

  Kljajic, Sonja Tesanovic ^a   Widdop, Robert E ^a   Vinh, Antony ^a   Welungoda, Iresha ^a   Bosnyak, Sanja ^a   Jones, Emma S ^a   Gaspari, Tracey A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

AT 2 receptor; Atherosclerosis; CGP42112; Endothelial dysfunction; Plaque rupture

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; APOLIPOPROTEIN E; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOAVAILABILITY; BLOOD VESSEL REACTIVITY; BRACHIOCEPHALIC TRUNK; CELL ADHESION; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; HEART PROTECTION; IMMUNOREACTIVITY; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION;

AT(2) RECEPTOR; ATHEROSCLEROSIS; CGP42112; ENDOTHELIAL DYSFUNCTION; PLAQUE RUPTURE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CARDIOTONIC AGENTS; COHORT STUDIES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGOPEPTIDES; PLAQUE, ATHEROSCLEROTIC; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 84887464036     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.09.015     Document Type: Article

References (36)

1. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International Union of Pharmacology. XXIII. The angiotensin II receptors Pharmacol Rev 52 3 2000 415 472
2. J.F. Keaney Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction Mol Aspects Med 21 4-5 2000 99 166
3. P. Libby Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation Circ Res 2007 299 301
4. E. Schulz, E. Anter, and J.F. Keaney Oxidative stress, antioxidants, and endothelial function Curr Med Chem 11 2004 1093 1104
5. V.J. Dzau, R.C. Braun-Dullaeus, and D.G. Sedding Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies Nat Med 8 2002 1249 1256
6. M.A. Zaman, S. Oparil, and A. Calhoun Drugs targeting the renin-angiotensin-aldosterone system Nat Rev Drug Discov 1 2002 621 626
7. S. Wassmann, T. Czech, M. van Eickels, I. Fleming, M. Bohm, and G. Nickenig Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice Circulation 110 2004 3062 3067
8. E.S. Jones, A. Vinh, C.A. McCarthy, T.A. Gaspari, and R.E. Widdop AT2 receptors: functional relevance in cardiovascular disease Pharmacol Ther 120 3 2008 292 316
9. R.E. Widdop, E.S. Jones, R.E. Hannan, and T.A. Gaspari Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 140 5 2003 809 824
10. E.S. Jones, M.J. Black, and R.E. Widdop Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade J Mol Cell Cardiol 37 5 2004 1023 1030
11. M. Iwai, R. Chen, and Z. Li Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice Circulation 112 11 2005 1636 1643
12. V.L. Sales, G.K. Sukhova, M.A. Lopez-Ilasaca, P. Libby, V.J. Dzau, and R.E. Pratt Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution Circulation 112 21 2005 3328 3336
13. A. Daugherty, D.L. Rateri, H. Lu, T. Inagami, and L.A. Cassis Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor Circulation 110 25 2004 3849 3857
14. V. Tiyerili, C.F. Mueller, and U.M. Becher Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice J Mol Cell Cardiol 52 3 2012 630 637
15. A. Daugherty, M.W. Manning, and L.A. Cassis Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis Br J Pharmacol 134 2001 865 870
16. M.E. Johansson, W. Anna, M. FS, G. Li-ming, and G. Bergstrom Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE -/- mice J Hypertens 23 8 2005 1541 1550
17. M.E. Johansson, A. Wickman, O. Skott, L.M. Gan, and G. Bergstrom Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE -/- mice J Hypertens 24 10 2006 2001 2008
18. M. Naghavi, P. Libby, and E. Falk From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I Circulation 108 14 2003 1664 1672
19. M.X.H. Zhou, L. Pan, J. Wen, Y. Guo, and K. Chen Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice J Exp Med 215 1 2008 61 69
20. E.P.M. Blessing, R. Kranzhofer, and R. Kinscherf Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apoliporotein E deficient mice Atherosclerosis 199 2 2008 295 303
21. F.F.M. Cipollone, A. Iezzi, and B. Pini Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity Circulation 109 2004 1482 1488
22. M.L.D. Nakamura, and A.C. Yeung Identification and treatment of vulnerable plaque Rev Cardiovasc Med 5 2004 S22 S33
23. S. Tesanovic, VA, T.A. Gaspari, D. Casley, and R.E. Widdop Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 30 2010 1606 1613
24. A. Vinh, R.E. Widdop, G.R. Drummond, and T.A. Gaspari Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice Cardiovasc Res 77 1 2008 178 187
25. S. Kawashima Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis J Pharmacol Sci 96 2004 411 419
26. H. Hiyoshi, K. Yayama, M. Takano, and H. Okamoto Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension Hypertension 45 5 2005 967 973
27. C. Hu, A. Dandapat, and J. Chen Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression Atherosclerosis 199 2 2008 288 294
28. K. Yayama, H. Hiyoshi, D. Imazu, and H. Okamoto Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor Hypertension 48 5 2006 958 964
29. S. Heumuller, S. Wind, and E. Barbosa-Sicard apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant Hypertension 51 2 2008 211 217
30. Y. Nakashima, A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree Arterioscler Thromb Vasc Biol 14 1994 133 140
31. E. Lutgens, vSR-J, and B.C. Faber Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol 23 2003 2123 2130
32. H. Williams, JJ, K.G.S. Carson, and C.L. Jackson Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice Arterioscler Thromb Vasc Biol 2002 2002 788 792
33. M. Mifune, SH, R. Shimizu-Hirota, H. Miyazaki, and T. Saruta Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells Hypertension 36 2000 845 850
34. T.W.H. Jing, K.S. Srivenugopal, G. He, J. Liu, L. Miao, and Y. He Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling Int J Mol Med 24 2009 103 110
35. A.C. Newby Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability Arterioscler Thromb Vasc Biol 28 12 2008 2108 2114
36. F. Rompe, M. Artuc, and A. Hallberg Direct angiotensin II Type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor {kappa}B Hypertension 55 4 2010 924 931